 |
|
Association Between Depressive Symptoms and Mortality in Older Women
Mary A. Whooley, MD;
Warren S. Browner, MD, MPH;
for the Study of Osteoporotic Fractures Research Group
Arch Intern Med. 1998;158:2129-2135.
ABSTRACT
| |
Background Major depression is associated with increased mortality, but it is not known whether patients who report depressive symptoms have greater mortality.
Subjects and Methods We performed a prospective cohort study of 7518 white women 67 years of age or older who were recruited from population-based listings in Baltimore, Md, Minneapolis, Minn, Portland, Ore, and the Monongahela Valley, Pa. Participants completed the Geriatric Depression Scale (short form) and were considered depressed if they reported 6 or more of 15 possible symptoms of depression. Women were followed up for an average of 6 years. If a participant died, we obtained a copy of the official death certificate and hospital records, if available, and used International Classification of Diseases, Ninth Revision, codes to classify death attributable to cardiovascular, cancer, or noncancer, noncardiovascular cause.
Results Mortality during 7-year follow-up varied from 7% in women with no depressive symptoms to 17% in those with 3 to 5 symptoms to 24% in those with 6 or more symptoms of depression (P<.001). Of 473 women (6.3%) with 6 or more depressive symptoms at baseline, 24% died (111 deaths in 2610 woman-years of follow-up) compared with 11% of women who reported 5 or fewer symptoms of depression (760 deaths in 41460 woman-years of follow-up) (P<.001). Women with 6 or more depressive symptoms had a 2-fold increased risk of death (age-adjusted hazard ratio [HR], 2.14; 95% confidence interval [CI], 1.75-2.61; P<.001) compared with those who had 5 or fewer depressive symptoms. This association remained strong after adjusting for potential confounding variables, including history of myocardial infarction, stroke, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, smoking, perceived health, and cognitive function (HR, 1.47; 95% CI, 1.14-1.88; P =.003). Depressive symptoms were associated with an increased adjusted risk of death from cardiovascular diseases (HR, 1.8; 95% CI, 1.2-2.5; P=.003), and noncancer, noncardiovascular diseases (HR, 1.8; 95% CI, 1.2-2.7; P=.01), but were not associated with deaths from cancer (HR, 1.0; 95% CI, 0.6-1.7; P=.93).
Conclusions Depressive symptoms are a significant risk factor for cardiovascular and noncancer, noncardiovascular mortality but not cancer mortality in older women. Whether depressive symptoms are a marker for, or a cause of, life-threatening conditions remains to be determined.
INTRODUCTION
MANY STUDIES1-13 have found that clinically diagnosed major depression is associated with increased mortality, but it is unclear whether depressive symptoms, such as those recognized in a routine office visit or on a simple screening instrument, predict mortality. Prior studies14-20 have found that depressive symptoms are associated with poor health and functional status, as well as increased disability, health care utilization, and cost of health services. However, results have been inconsistent regarding a possible association between depressive symptoms and mortality.
Two large studies21-22 found no association between baseline depressive symptoms and subsequent mortality, but 2 others23-24 reported greater mortality in patients with depressive symptoms. Of these 2 studies, one23 was limited to patients with preexisting coronary artery disease and the other24 did not control for comorbid illnesses. Neither examined mortality from causes other than ischemic heart disease.
We measured depressive symptoms in a cohort of older women and followed them up for an average of 6 years. We examined the association between depressive symptoms and mortality from specific causes such as coronary heart disease, cerebrovascular disease, congestive heart failure, cancer, and chronic obstructive pulmonary disease.
SUBJECTS AND METHODS
SUBJECTS
A total of 9704 ambulatory women at least 65 years of age were recruited from population-based listings in Baltimore, Md, Minneapolis, Minn, Portland, Ore, and the Monongahela Valley, Pa, between 1986 and 1988 for the Study of Osteoporotic Fractures, a prospective cohort study designed to determine risk factors for osteoporotic fractures. At a second visit (1988-1990), 7518 of these women (80% of survivors) completed at least 10 of 15 items on the Geriatric Depression Scale. These 7518 women are the subjects of this secondary data analysis. The study was approved by the appropriate institutional review boards, and all subjects provided written informed consent.
MEASUREMENTS
Depressive Symptoms
At the second visit (1988-1990), we administered the Geriatric Depression Scale short form, a validated, reliable, 15-item, self-report, depressive symptoms checklist designed to detect the presence of current depression in the elderly.25 Using a cutoff point of 6 or more symptoms, the Geriatric Depression Scale short form has a sensitivity of 88% and specificity of 62% compared with a structured clinical interview for depression.26 We defined depression as 6 or more symptoms, with 6 to 7 symptoms indicating mild depression, 8 to 10 symptoms indicating moderate depression, and 11 or more symptoms indicating severe depression.27 For participants who failed to complete all 15 items, we calculated the total number of depressive symptoms by dividing the reported number of symptoms by the proportion of items completed. To determine the effect of persistent depressive symptoms on subsequent mortality, we also administered the same instrument 4 years later (1992-1994) to 5837 of the original 7518 women (83% of survivors).
Other Measurements
Self-reported age, marital status, education, medical history, current perceived health status (excellent/good vs fair/poor/very poor), smoking, alcohol, and use of benzodiazepine, barbiturates, thiazide diuretics, and estrogen were determined from a questionnaire administered at the first visit and reviewed by an interviewer. Systolic and diastolic blood pressures were measured at the right brachial artery using a standard protocol.28 Hypertension was defined as systolic blood pressure higher than 160 mm Hg, diastolic blood pressures higher than 90 mm Hg, or use of a thiazide diuretic. We measured social network by scoring answers to 11 questions regarding contact with spouse, relatives, and friends, then adding scores for the individual questions to create a total social network score. Higher scores indicate better social network.
Physical activity was estimated using a modified Paffenbarger scale that assesses the type and duration of weight-bearing activities in a variety of settings.29 Participants were asked about the frequency with which they performed each of 40 activities at 4 time points during their lives (teenager, age 30 years, age 50 years, and previous year). For each of the 4 time points, the number of times per year each activity was performed was multiplied by 5.0 for low-intensity (eg, walking or gardening), 7.5 for medium-intensity (eg, dancing or tennis), or 10.0 for high-intensity activities (eg, jogging or skiing). Scores for these 4 time points were added to calculate lifetime physical activity.
At the second visit, weight was measured (in light indoor clothing with shoes removed) using a balance beam scale, and height was measured using a stadiometer.30 Body mass index was calculated as weight in kilograms divided by the square of the height in meters. Cognitive function was measured by a trained examiner using Digit Symbol, a subtest of the Wechsler Adult Intelligence Scale.31 Scores on Digit Symbol reflect the number correct within the timed trial; thus, lower scores indicate poorer performance.
Functional Status
To determine whether impaired functional status is an antecedent of depressive symptoms (ie, potential cause of both depression and mortality that should be adjusted for in the primary analysis) or an effect of depressive symptoms (ie, potential mechanism linking depressive symptoms and mortality that should not be adjusted for in the primary analysis), we measured functional status and depressive symptoms at 2 time points: at the 1988-1990 visit and again 4 years later.
Functional status was measured on a 39-point scale with up to 3 points (some difficulty, much difficulty, or unable to do) for each of 13 activities (eg, dressing, bathing, preparing meals, doing housework, shopping, or walking 2 or 3 blocks) based on a modified version of the Stanford Health Assessment Questionnaire.32 We defined impaired functional status as a score of 14 or more because this number required that the respondent report much difficulty with at least 1 of the 13 activities.
To ascertain whether impaired functional status precedes the development of depressive symptoms, we first excluded women who had 6 or more depressive symptoms in 1988-1990, and then measured the incidence of depression (defined as a score  6 on the Geriatric Depression Scale in 1992-1994), comparing women who had impaired functional status in 1988-1990 with those who had normal functional status at that time. To ascertain whether impaired functional status is an effect of depressive symptoms, we first excluded women who had impaired functional status in 1988-1990, and then measured the incidence of impaired functional status (score 14) in the ensuing 4 years, comparing women who had 6 or more depressive symptoms in 1988-1990 with those who had 5 or fewer symptoms at that time.
Mortality
Mortality was ascertained for an average of 6 years (range, up to 7 years) following the initial depression measure. If a participant died, we obtained a copy of the official death certificate and hospital records, if available; the cause of death was assigned by one of us (W.S.B.) who was unaware of results from the Geriatric Depression Scale or other predictor measurements. We used International Classification of Diseases, Ninth Revision codes33 to classify death due to cardiovascular (codes 394-402, 410-414, 424-444, and 798), cancer (codes 141-238 and 259), or noncancer, noncardiovascular cause. We specifically identified deaths from coronary heart disease (codes 410-414 and 429), cerebrovascular disease (codes 430-438), congestive heart failure (code 425), sudden death (code 798), lung cancer (codes 162-163), breast cancer (code 174), colon cancer (codes 153-154), chronic obstructive pulmonary disease (codes 491-496), pneumonia (code 486), accidents and trauma (codes 800-805, 852-994, and E812-E890), and natural causes (code 799.9). Three women who died from suicide were excluded from all analyses.
STATISTICAL ANALYSIS
Differences in baseline characteristics between women with and without depression were compared using  2 tests for dichotomous variables and t tests for continuous variables. The association between depressive symptoms and mortality was analyzed using proportional hazards models. We used forward stepwise proportional hazards regression to obtain adjusted risk estimates, adding those variables associated with mortality (at P<.05) to multivariate models that included depression. We verified the proportionality assumption of these models. The association between depressive symptoms and functional status was analyzed using logistic regression. For all analyses, we report the hazard ratio (HR) or odds ratio (OR) with 95% confidence intervals (CIs). Survival curves were estimated using an adjusted Cox proportional hazards model.34 Analyses were performed with the use of SAS statistical software (SAS Institute Inc, Cary, NC).
RESULTS
The prevalence of depression (defined as a score 6 on the Geriatric Depression Scale short form) was 6.3% (473/7518). Compared with those who had 5 or fewer symptoms of depression, women with 6 or more symptoms were older and more likely to smoke or to report fair or poor health. They had a higher frequency of medical illnesses, worse functional status, and worse cognitive function. They were less likely to be married, well-educated, or physically active (Table 1). Follow-up was complete in 7406 women (99%) who completed the depression scale. Of the 112 women lost to follow-up, 5.4% had 6 or more depressive symptoms. Mortality varied from 7% in women with no depressive symptoms to 17% in those with 3 to 5 symptoms to 24% in those with 6 or more symptoms of depression (P<.001 for trend) (Figure 1).
|
|
|
|
Table 1. Characteristics of Participants*
|
|
|
|
|
|
|
Figure 1. Mortality during 7-year follow-up by number of depressive symptoms in 7518 elderly women. Bars represent 95% confidence intervals. P<.001 for trend.
|
|
|
Deaths occurred in 24% of women with 6 or more depressive symptoms (111 deaths in 2610 woman-years of follow-up) and 11% of women with 5 or fewer depressive symptoms (760 deaths in 41460 woman-years of follow-up) (P<.001). Participants who subsequently died had a mean (±SD) depression score of 2.6 ± 2.7, compared with 1.6 ± 2.1 in participants who were alive at follow-up (P<.001).
Women with 6 or more depressive symptoms had a 2-fold increased risk of death (age-adjusted HR, 2.14; 95% CI, 1.75-2.61; P<.001) compared with those who had 5 or fewer symptoms. This association remained strong after adjusting for potential confounding variables (HR, 1.47; 95% CI, 1.14-1.88; P=.003) (Table 2). Each 1-symptom increase in number of depressive symptoms was associated with a 6% increase in all-cause mortality (HR, 1.06; 95% CI, 1.03-1.10; P<.001), adjusting for history of myocardial infarction, stroke, chronic obstructive pulmonary disease, diabetes mellitus, hypertension, smoking, perceived health, and cognitive function.
|
|
|
|
Table 2. Age-Adjusted Multivariate Hazard Model of Predictors of Mortality in 6176 Elderly Women*
|
|
|
Of 473 women who had 6 or more depressive symptoms in 1988-1990, 297 completed the Geriatric Depression Scale short form again 4 years later, and 159 (53.5%) of 297 had persistent depressive symptoms. Death occurred in 11.3% of women with 6 or more depressive symptoms at both time points (18 deaths in 971 woman-years of follow-up) and 4.3% of women with 5 or fewer depressive symptoms at both time points (223 deaths in 32232 woman-years of follow-up) (P<.001). Women with persistent depressive symptoms had a 2.5-fold increased risk of death (age-adjusted HR, 2.53; 95% CI, 1.56-4.09; P <.001) compared with those who reported 5 or fewer symptoms at both time points, an association that persisted but did not remain statistically significant after adjusting for the variables listed in Table 2 (HR, 1.63; 95% CI, 0.86-3.07; P=.13).
We found that depressive symptoms are both a cause and an effect of impaired functional status. Among the 7045 participants who had 5 or fewer depressive symptoms in 1988-1990, those with impaired functional status (n=172) had a mean (±SD) depression score of 3.5 ± 2.8 at follow-up compared with 1.6 ± 1.9 in women with normal functional status (P<.001); women with impaired functional status were more likely to develop depressive symptoms than those with normal functional status (24% vs 5%; OR, 5.4; 95% CI, 3.3-8.5; P <.001). Among the 7277 participants who had normal functional status in 1988-1990, women with 6 or more depressive symptoms had a mean (±SD) functional status score of 5.2 ± 6.1 at follow-up, compared with 2.1 ± 4.3 in women with 5 or fewer depressive symptoms (P<.001); those with 6 or more depressive symptoms were more likely to develop impaired functional status than those with 5 or fewer symptoms of depression (11% vs 3%; OR, 3.6; 95% CI, 2.4-5.3; P<.001). When added to the model in Table 2, adjustment for functional status (as a continuous variable) appeared to attenuate but not eliminate the association between depressive symptoms and mortality (HR, 1.31; 95% CI, 1.02-1.69; P =.03).
Mortality rates in women with and without depression did not appear to diverge until approximately 16 months of follow-up (Figure 2). In models adjusted for the variables listed in Table 2, women with depressive symptoms had an 80% increased risk of cardiovascular death and an 80% increased risk of noncancer, noncardiovascular death, including a 3-fold increased risk of death from chronic obstructive pulmonary disease, but no increased risk of death from cancer (Table 3).
|
|
|
|
Figure 2. Survival during 7-year follow-up in 6176 elderly women (adjusted for variables in Table 2).
|
|
|
|
|
|
|
Table 3. Relative Mortality From Specific Causes in Women With Depression Compared With Women Without Depression*
|
|
|
COMMENT
Elderly women with 6 or more depressive symptoms had a 47% increased adjusted risk of all-cause mortality, including an 80% increased risk of dying of cardiovascular disease and noncancer, noncardiovascular disease, compared with women who reported 5 or fewer symptoms of depression. This increased risk is similar to that conferred by other cardiovascular risk factors, such as hypertension, cigarette smoking, hyperlipidemia, obesity, and diabetes.35 Mortality increased with number of depressive symptoms, suggesting a dose-response relationship. Increased mortality in women with depression compared with women without depression did not occur until approximately 16 months of follow-up, indicating that depression is not simply a result of life-threatening conditions.
Why would women with depressive symptoms have increased mortality, and in particular increased cardiovascular mortality? Several possible mechanisms have been suggested. Electrocardiographic evidence of myocardial ischemia during daily life has been demonstrated in the hour following high levels of sadness, suggesting that myocardial ischemia may be a direct result of depressed mood.36 Depression has been identified as a predictor of hypertension,37 autonomic dysfunction as measured by higher plasma levels of norepinephrine and reduced heart rate variability,38-45 increased platelet reactivity,46-48 and cardiovascular events including myocardial infarction.6, 11, 22, 24, 49 Use of psychotropic medications, such as antidepressants, barbiturates, phenothiazines, and lithium, have been associated with mortality, although most likely as markers of depression rather than links in the pathway between depression and mortality.11, 50
We did not measure hyperlipidemia as a potential risk factor for cardiovascular mortality among women with depressive symptoms, but it is unlikely that hyperlipidemia would explain the association between depressive symptoms and mortality because depression is probably associated with low rather than high cholesterol levels.51-53 Patients with depression are less likely than patients without depression to adhere to prescribed exercise therapy,54-55 and lack of exercise has been associated with poor health outcomes.29, 56-57 Our analysis adjusted for self-reported physical activity, but subsequent lack of exercise might have explained the association between depression and mortality. Decreased compliance with medications58 and lack of social support among patients with depressive symptoms also may contribute to the association between depressive symptoms and mortality.59-61
Another potential explanation is that the association between depressive symptoms and mortality may be partially confounded by impaired functional status. Our findings suggest that impaired functional status is both a cause and an effect of depression. To avoid overadjusting for the effects of depression in our primary analysis, we adjusted for impaired functional status in a separate analysis and found that the association between depressive symptoms and mortality was somewhat attenuated. We cannot determine whether this occurred because impaired functional status was a cause of depressive symptoms or a result of depressive symptoms that subsequently led to increased mortality.
Depressive symptoms could be a marker of other illnesses that are associated with increased mortality. If a greater prevalence of other illnesses explained the association between depressive symptoms and mortality, however, we would expect that mortality rates would diverge before 16 months of follow-up and that depressive symptoms also would be associated with increased cancer mortality. Prior studies62-64 have yielded conflicting results regarding the possibility that stressful life events and depression contribute to the onset and progression of cancer, particularly breast cancer. We found no increased risk of subsequent death from cancer among women with depressive symptoms.
Our findings differ from those of 2 prior studies21-22 that found no association between baseline depressive symptoms and subsequent mortality. One study21 enrolled members of a health maintenance organization who were younger than the participants in this study. The other22 enrolled patients with hypertension and found that, although baseline depressive symptoms were not associated with mortality, an increase in number of depressive symptoms over time was associated with increased mortality, including fatal stroke and fatal myocardial infarction.
Several limitations deserve comment. First, only 80% of survivors from the initial cohort completed the depression measure; women included in this analysis may have been less depressed than those who did not complete the depression measure. Second, although we measured many potential confounding variables, the association between depressive symptoms and mortality may be influenced by unmeasured variables, such as use of antidepressant medications or chronic medical illnesses that were not identified by self-report. Third, we measured depressive symptoms rather than performing a clinical interview for depression; thus, we must conclude that depressive symptoms, and not necessarily the diagnosis of depression, are associated with increased mortality. Fourth, cause of death may be misclassified due to the potential inaccuracies of death certificates. Finally, we studied only elderly white women, whose characteristics may differ from those of other populations.
CONCLUSIONS
Depression is a common and readily treatable condition among older adults, but few receive appropriate treatment.65 Depressive symptoms are associated with increased cardiovascular and noncancer, noncardiovascular mortality in older women. Although the effect of treatment for depressive symptoms on mortality remains to be determined, these findings suggest that treatment for depression may not only enhance quality of life but also reduce mortality among women with depressive symptoms. We should redouble our efforts to improve detection and treatment of depression.
AUTHOR INFORMATION
Accepted for publication January 12, 1998.
This study was supported by grants AG05394, AG05407, AR35582, AR35583, AR35584, and NS36016 from the US Public Health Service.
We are indebted to Li-Yung Lily Lui, MA, MS, for her assistance with data analysis.
The Study of Osteoporotic Fractures Research Group
University of California, San Francisco (Coordinating Center): S. R. Cummings, MD (principal investigator); M. C. Nevitt, PhD (coinvestigator); D. G. Seeley, PhD (project director); D. M. Black, PhD (study statistician); H. K. Genant, MD (director, central radiology laboratory); C. Arnaud, MD; D. Bauer, MD; W. Browner, MD; L. Christianson; M. Dockrell; C. Fox, MA; R. Gore, PhD; S. Harvey; M. Jaime-Chavez, PhD; L. Laidlaw; R. Lipschutz, MPH; L. Lui, MA, MS; G. Milani; L. Palermo, MS; R. San Valentin, MD; K. Stone, MA; H. Tabor; D. Tanaka; C. Yeung. University of Maryland, Baltimore: J. C. Scott, RN, DrPH (principal investigator); R. Sherwin, MD (coinvestigator); M. C. Hochberg, MD (coinvestigator); J. Lewis, RN (project director); E. Peddicord, RN (clinic coordinator); A. Bauer; C. Boehm; G. Cullum; L. Finazzo; M. E. Flaks; T. Ford; D. Harris; B. Hohman, RN; E. Oliner; T. Page; J. Schlossberg; C. Shaffer; A. Trimble; S. Trusty. University of Minnesota, Minneapolis: K. Ensrud, MD, MPH (principal investigator); P. Schreiner, PhD (coinvestigator); C. Bell, MBA (project director); E. Mitson (clinic coordinator); C. Bird; D. Blanks; S. Estill; S. Fillhouer; S. Fincham; J. Griffith, MA; J. Hansen; F. Imker-Witte; K. Jacobson; K. Kiel; K. Knauth, RN; N. Nelson; E. Penland-Miller; M. Riley-Alves. University of Pittsburgh, Pittsburgh, Pa: J. A. Cauley, DrPH (principal investigator); L. H. Kuller, MD (coprincipal investigator); M. Vogt, PhD (coinvestigator); L. Harper (project director); L. Buck, RN (clinic coordinator); C. Bashada; D. Cusick; G. Engleka; A. Githens; M. Gorecki; K. McCune, RN; D. Medve; M. Nasim, RN; C. Newman; S. Rudovsky; N. Watson. The Kaiser Permanente Center for Health Research, Portland, Ore: E. Harris, PhD (principal investigator, project director); W. M. Vollmer, PhD; E. Orwoll, MD, and H. Nelson, MD (coinvestigators); K. Crannell, RN (project administrator, clinic coordinator); J. Bender, RN; A. Doherty; K. Easter; M. Erwin; F. Heinith, RN; J. Kann; K. Redden; C. Romero; K. Snider; C. Souvanlasy.
Reprints: Mary A. Whooley, MD, General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, 4150 Clement St, 111A1, San Francisco, CA 94121 (e-mail: whooley{at}itsa.ucsf.edu).
From the General Internal Medicine Section, San Francisco Department of Veterans Affairs Medical Center, and the Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco.
REFERENCES
| |
1. Tsuang MT, Woolson RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry. 1980;136:239-242.
FREE FULL TEXT
2. Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH. Affective disorders and mortality: a general population study. Arch Gen Psychiatry. 1987;44:473-480.
FREE FULL TEXT
3. Black DW, Winokur G, Nasrallah A. Mortality in patients with primary unipolar depression, secondary unipolar depression, and bipolar affective disorder: a comparison with general population mortality. Int J Psychiatry Med. 1987;17:351-360.
ISI
| PUBMED
4. Bruce ML, Leaf PJ. Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health. 1989;79:727-730.
FREE FULL TEXT
5. Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG. Survival and health care utilization in elderly medical inpatients with major depression. J Am Geriatr Soc. 1989;37:599-606.
ISI
| PUBMED
6. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270:1819-1825. [erratum appears in JAMA. 1994;271:1082].
FREE FULL TEXT
7. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med. 1993;94(suppl 5A):19S-22S.
8. Aromaa A, Raitasalo R, Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiatr Scand Suppl. 1994;377:77-82.
PUBMED
9. Bruce ML, Leaf PJ, Rozal GP, Florio L, Hoff RA. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry. 1994;151:716-721.
FREE FULL TEXT
10. Kouzis A, Eaton WW, Leaf PJ. Psychopathology and mortality in the general population. Soc Psychiatry Psychiatr Epidemiol. 1995;30:165-170.
FULL TEXT
|
ISI
| PUBMED
11. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 1996;94:3123-3129.
FREE FULL TEXT
12. Ganzini L, Smith DM, Fenn DS, Lee MA. Depression and mortality in medically ill older adults. J Am Geriatr Soc. 1997;45:307-312.
ISI
| PUBMED
13. Zheng D, Macera CA, Croft JB, Giles WH, Davis D, Scott WK. Major depression and all-cause mortality among white adults in the United States. Ann Epidemiol. 1997;7:213-218.
FULL TEXT
|
ISI
| PUBMED
14. Unutzer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA. 1997;277:1618-1623.
FREE FULL TEXT
15. Covinsky KE, Fortinsky RH, Palmer RM, Kresevic DM, Landefeld CS. Relation between symptoms of depression and health status outcomes in acutely ill hospitalized older persons. Ann Intern Med. 1997;126:417-425.
FREE FULL TEXT
16. Bruce ML, Seeman TE, Merrill SS, Blazer DG. The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. Am J Public Health. 1994;84:1796-1799.
FREE FULL TEXT
17. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992;267:1478-1483.
FREE FULL TEXT
18. Katon W, Sullivan M, Russo J, Dobie R, Sakai C. Depressive symptoms and measures of disability: a prospective study. J Affect Disord. 1993;27:245-254.
FULL TEXT
|
ISI
| PUBMED
19. Shea MT, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry. 1992;49:782-787.
FREE FULL TEXT
20. Gallo JJ, Rabins PV, Lyketsos CG, Tien AY, Anthony JC. Depression without sadness: functional outcomes of nondysphoric depression in later life. J Am Geriatr Soc. 1997;45:570-578.
ISI
| PUBMED
21. Vogt T, Pope C, Mullooly J, Hollis J. Mental health status as a predictor of morbidity and mortality: a 15-year follow-up of members of a health maintenance organization. Am J Public Health. 1994;84:227-231.
FREE FULL TEXT
22. Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events: SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med. 1996;156:553-561.
FREE FULL TEXT
23. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613-617.
FULL TEXT
|
ISI
| PUBMED
24. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976-1980.
FREE FULL TEXT
25. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709-711.
ISI
| PUBMED
26. Gerety MB, Williams J Jr, Mulrow CD, et al. Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc. 1994;42:1103-1109.
ISI
| PUBMED
27. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165-173.
28. Vogt MT, Cauley JA, Kuller LH, Hulley SB. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol. 1993;137:559-568.
FREE FULL TEXT
29. Paffenbarger RSJ, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978;108:161-175.
FREE FULL TEXT
30. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, Ill: Human Kinetics Books; 1988.
31. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: Psychological Corp; 1988.
32. Pincus T, Summey JA, Soraci S Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346-1353.
ISI
| PUBMED
33. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
34. Cox DR. Regression models and life tables (with discussion). J R Stat Soc. 1972;B34:187-220.
35. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984;76:4-12.
FULL TEXT
|
ISI
| PUBMED
36. Gullette EC, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA. 1997;277:1521-1526.
FREE FULL TEXT
37. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? longitudinal evidence from the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Fam Med. 1997;6:43-49.
FREE FULL TEXT
38. Roy A, Pickar D, Linnoila M, Potter WZ. Plasma norepinephrine level in affective disorders: relationship to melancholia. Arch Gen Psychiatry. 1985;42:1181-1185.
FREE FULL TEXT
39. Esler M, Turbott J, Schwarz R, et al. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry. 1982;39:295-300.
FREE FULL TEXT
40. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry. 1982;139:1315-1318.
FREE FULL TEXT
41. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res. 1988;32:159-164.
FULL TEXT
|
ISI
| PUBMED
42. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50:627-633.
FREE FULL TEXT
43. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 1995;76:562-564.
FULL TEXT
|
ISI
| PUBMED
44. Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord. 1994;32:271-275.
FULL TEXT
|
ISI
| PUBMED
45. Kleiger RE, Miller JP, Bigger J Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
FULL TEXT
|
ISI
| PUBMED
46. Mikuni M, Kagaya A, Takahashi K, Meltzer HY. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders. Psychopharmacology. 1992;106:311-314.
FULL TEXT
| PUBMED
47. Grignani G, Pacchiarini L, Zucchella M, et al. Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease. Haemostasis. 1992;22:138-146.
ISI
| PUBMED
48. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313-1317.
FREE FULL TEXT
49. Kubzansky LD, Kawachi I, Spiro Ar, Weiss ST, Vokonas PS, Sparrow D. Is worrying bad for your heart? a prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation. 1997;95:818-824.
FREE FULL TEXT
50. Bingefors K, Isacson D, Knorring LV, Smedby B, Wicknertz K. Antidepressant-treated patients in ambulatory care: mortality during a nine-year period after first treatment. Br J Psychiatry. 1996;169:647-654.
FREE FULL TEXT
51. Lindberg G, Larsson G, Setterlind S, Rastam L. Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health. 1994;48:360-363.
FREE FULL TEXT
52. Davidson KW, Reddy S, McGrath P, Zitner D, MacKeen W. Increases in depression after cholesterol-lowering drug treatment. Behav Med. 1996;22:82-84.
ISI
| PUBMED
53. Brown SL, Salive ME, Harris TB, Simonsick EM, Guralnik JM, Kohout FJ. Low cholesterol concentrations and severe depressive symptoms in elderly people. BMJ. 1994;308:1328-1332.
FREE FULL TEXT
54. Blumenthal JA, Williams RS, Wallace AG, Williams R Jr, Needles TL. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med. 1982;44:519-527.
FREE FULL TEXT
55. Finnegan DL, Suler JR. Psychological factors associated with maintenance of improved health behaviors in postcoronary patients. J Psychol. 1985;119:87-94.
ISI
| PUBMED
56. Kallio V, Hamalainen H, Hakkila J, Luurila OJ. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction. Lancet. 1979;2:1091-1094.
ISI
| PUBMED
57. Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, Greenfield S. Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study. J Clin Epidemiol. 1994;47:719-730.
FULL TEXT
|
ISI
| PUBMED
58. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88-90.
FULL TEXT
|
ISI
| PUBMED
59. Moos RH. Depressed outpatients' life contexts, amount of treatment, and treatment outcome. J Nerv Ment Dis. 1990;178:105-112.
ISI
| PUBMED
60. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186-204.
FREE FULL TEXT
61. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540-545.
FREE FULL TEXT
62. Roberts FD, Newcomb PA, Trentham-Dietz A, Storer BE. Self-reported stress and risk of breast cancer. Cancer. 1996;77:1089-1093.
FULL TEXT
|
ISI
| PUBMED
63. Chen CC, David AS, Nunnerley H, et al. Adverse life events and breast cancer: case-control study. BMJ. 1995;311:1527-1530.
FREE FULL TEXT
64. Ginsberg A, Price S, Ingram D, Nottage E. Life events and the risk of breast cancer: a case-control study. Eur J Cancer. 1996;32A(12):2049-2052.
65. Depression Guideline Panel. Depression in Primary Care: Detection and Diagnosis—Clinical Practice Guideline. Washington, DC: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0550.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Subtle Neurological Abnormalities as Risk Factors for Cognitive and Functional Decline, Cerebrovascular Events, and Mortality in Older Community-Dwelling Adults
Inzitari et al.
Arch Intern Med 2008;168:1270-1276.
ABSTRACT
| FULL TEXT
Comparison of 2 Frailty Indexes for Prediction of Falls, Disability, Fractures, and Death in Older Women
Ensrud et al.
Arch Intern Med 2008;168:382-389.
ABSTRACT
| FULL TEXT
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
Nicholson et al.
Eur Heart J 2006;27:2763-2774.
ABSTRACT
| FULL TEXT
Depression Symptom Severity and Reported Treatment History in the Prediction of Cardiac Risk in Women With Suspected Myocardial Ischemia: The NHLBI-Sponsored WISE Study.
Rutledge et al.
Arch Gen Psychiatry 2006;63:874-880.
ABSTRACT
| FULL TEXT
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
McCaffery et al.
Psychosom. Med. 2006;68:187-200.
ABSTRACT
| FULL TEXT
Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study.
Rutledge et al.
Psychosom. Med. 2006;68:217-223.
ABSTRACT
| FULL TEXT
Rethinking Gender Differences in Health: Why We Need to Integrate Social and Biological Perspectives
Rieker and Bird
Journals of Gerontology Series B: Psychological Sciences and Social Science 2005;60:S40-S47.
ABSTRACT
| FULL TEXT
Depressive Symptoms Are Associated With Increased Systemic Vascular Resistance to Stress
Matthews et al.
Psychosom. Med. 2005;67:509-513.
ABSTRACT
| FULL TEXT
Do Depressive Symptoms Predict Declines in Physical Performance in an Elderly, Biracial Population?
Everson-Rose et al.
Psychosom. Med. 2005;67:609-615.
ABSTRACT
| FULL TEXT
Black-White Differences in Depressive Symptoms Among Older Adults Over Time
Skarupski et al.
Journals of Gerontology Series B: Psychological Sciences and Social Science 2005;60:P136-P142.
ABSTRACT
| FULL TEXT
Reflections on Depression as a Cardiac Risk Factor
Frasure-Smith and Lesperance
Psychosom. Med. 2005;67:S19-S25.
ABSTRACT
| FULL TEXT
Depressive Symptoms and Mortality among Persons with and without Diabetes
Zhang et al.
Am J Epidemiol 2005;161:652-660.
ABSTRACT
| FULL TEXT
Patients With Depressive Symptoms Have Lower Health Status Benefits After Coronary Artery Bypass Surgery
Mallik et al.
Circulation 2005;111:271-277.
ABSTRACT
| FULL TEXT
Is Depression in Old Age Fatal Only When People Feel Lonely?
Stek et al.
Am. J. Psychiatry 2005;162:178-180.
ABSTRACT
| FULL TEXT
Cost-Utility Analysis Studies of Depression Management: A Systematic Review
Pirraglia et al.
Am. J. Psychiatry 2004;161:2155-2162.
ABSTRACT
| FULL TEXT
Depressive Symptoms and Mortality Risk in a National Sample: Confounding Effects of Health Status
Everson-Rose et al.
Psychosom. Med. 2004;66:823-830.
ABSTRACT
| FULL TEXT
Associations of Mortality With Ocular Disorders and an Intervention of High-Dose Antioxidants and Zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
AREDS Research Group
Arch Ophthalmol 2004;122:716-726.
ABSTRACT
| FULL TEXT
Depression and Cardiovascular Sequelae in Postmenopausal Women: The Women's Health Initiative (WHI)
Wassertheil-Smoller et al.
Arch Intern Med 2004;164:289-298.
ABSTRACT
| FULL TEXT
Negative Affect and Mortality in Older Persons
Wilson et al.
Am J Epidemiol 2003;158:827-835.
ABSTRACT
| FULL TEXT
The emotional dimension and the biological paradigm of illness: time for a change
Schattner
QJM 2003;96:617-621.
FULL TEXT
Social Networks and Marital Status Predict Mortality in Older Women: Prospective Evidence From the Study of Osteoporotic Fractures (SOF)
Rutledge et al.
Psychosom. Med. 2003;65:688-694.
ABSTRACT
| FULL TEXT
Additive Effects of Cognitive Function and Depressive Symptoms on Mortality in Elderly Community-Living Adults
Mehta et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M461-467.
ABSTRACT
| FULL TEXT
Association Between Depression and Elevated C-Reactive Protein
Danner et al.
Psychosom. Med. 2003;65:347-356.
ABSTRACT
| FULL TEXT
Psychotic Depression and Mortality
Vythilingam et al.
Am. J. Psychiatry 2003;160:574-576.
ABSTRACT
| FULL TEXT
Depressive Symptoms, Unemployment, and Loss of Income: The CARDIA Study
Whooley et al.
Arch Intern Med 2002;162:2614-2620.
ABSTRACT
| FULL TEXT
Mortality Risk Varies According to Gender and Change in Depressive Status in Very Old Adults
Anstey and Luszcz
Psychosom. Med. 2002;64:880-888.
ABSTRACT
| FULL TEXT
Depressive Symptoms and Negative Outcomes in Older Hospitalized Patients
Rozzini et al.
Arch Intern Med 2002;162:948-949.
FULL TEXT
Depression and Risk of Heart Failure Among the Elderly: A Prospective Community-Based Study
Williams et al.
Psychosom. Med. 2002;64:6-12.
ABSTRACT
| FULL TEXT
Depressive Symptoms as a Predictor of 6-Month Outcomes and Services Utilization in Elderly Medical Inpatients
Bula et al.
Arch Intern Med 2001;161:2609-2615.
ABSTRACT
| FULL TEXT
Visual Impairment, Age-Related Cataract, and Mortality
Wang et al.
Arch Ophthalmol 2001;119:1186-1190.
ABSTRACT
| FULL TEXT
Depressive symptoms and risk of functional decline and death in patients with heart failure
Vaccarino et al.
J Am Coll Cardiol 2001;38:199-205.
ABSTRACT
| FULL TEXT
Hopelessness Predicts Mortality in Older Mexican and European Americans
Stern et al.
Psychosom. Med. 2001;63:344-351.
ABSTRACT
| FULL TEXT
Depression and Cardiac Mortality: Results From a Community-Based Longitudinal Study
Penninx et al.
Arch Gen Psychiatry 2001;58:221-227.
ABSTRACT
| FULL TEXT
Racial Differences in Mortality Among Men Hospitalized in the Veterans Affairs Health Care System
Jha et al.
JAMA 2001;285:297-303.
ABSTRACT
| FULL TEXT
Managing Depression in Medical Outpatients
Whooley and Simon
NEJM 2000;343:1942-1950.
FULL TEXT
Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans
Ariyo et al.
Circulation 2000;102:1773-1779.
ABSTRACT
| FULL TEXT
Depressive Symptoms and 3-Year Mortality in Older Hospitalized Medical Patients
Covinsky et al.
ANN INTERN MED 1999;130:563-569.
ABSTRACT
| FULL TEXT
The Seduction of Death
Lesperance and Frasure-Smith
Psychosom. Med. 1999;61:18-20.
FULL TEXT
Depression and Mortality in Women
JWatch Psychiatry 1999;1999:15-15.
FULL TEXT
Depression and Mortality in Women
JWatch General 1998;1998:1-1.
FULL TEXT
|
